98 related articles for article (PubMed ID: 16513255)
1. Neuropeptide Y in neural crest-derived tumors: effect on growth and vascularization.
Kitlinska J
Cancer Lett; 2007 Jan; 245(1-2):293-302. PubMed ID: 16513255
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors.
Kitlinska J; Abe K; Kuo L; Pons J; Yu M; Li L; Tilan J; Everhart L; Lee EW; Zukowska Z; Toretsky JA
Cancer Res; 2005 Mar; 65(5):1719-28. PubMed ID: 15753367
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.
Tilan J; Kitlinska J
Neuropeptides; 2016 Feb; 55():55-66. PubMed ID: 26549645
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y (NPY) in neuroblastoma: effect on growth and vascularization.
Kitlinska J
Peptides; 2007 Feb; 28(2):405-12. PubMed ID: 17229489
[TBL] [Abstract][Full Text] [Related]
5. Evidence for further heterogeneity of the receptors for neuropeptide-Y and peptide-YY in tumor cell lines derived from neural crest.
Inui A; Sano K; Miura M; Hirosue Y; Nakajima M; Okita M; Baba S; Kasuga M
Endocrinology; 1992 Nov; 131(5):2090-6. PubMed ID: 1330489
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.
Tilan JU; Lu C; Galli S; Izycka-Swieszewska E; Earnest JP; Shabbir A; Everhart LM; Wang S; Martin S; Horton M; Mahajan A; Christian D; O'Neill A; Wang H; Zhuang T; Czarnecka M; Johnson MD; Toretsky JA; Kitlinska J
Oncotarget; 2013 Dec; 4(12):2487-501. PubMed ID: 24318733
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
8. Sonic Hedgehog pathway is essential for neuroblastoma cell proliferation and tumor growth.
Xu L; Wang X; Wan J; Li T; Gong X; Zhang K; Yi L; Xiang Z; Xu M; Cui H
Mol Cell Biochem; 2012 May; 364(1-2):235-41. PubMed ID: 22350753
[TBL] [Abstract][Full Text] [Related]
9. Functional expression of neuropeptide Y receptors in human neuroblastoma cells.
Li AJ; Ritter S
Regul Pept; 2005 Jul; 129(1-3):119-24. PubMed ID: 15927706
[TBL] [Abstract][Full Text] [Related]
10. High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche.
Pietras A; Gisselsson D; Ora I; Noguera R; Beckman S; Navarro S; Påhlman S
J Pathol; 2008 Mar; 214(4):482-8. PubMed ID: 18189331
[TBL] [Abstract][Full Text] [Related]
11. EGFR inhibition fails to suppress vascular proliferation and tumor growth in a Ewing's sarcoma model.
Chernoguz A; Crawford K; Donovan E; Vandersall A; Berglund C; Cripe TP; Frischer JS
J Surg Res; 2012 Mar; 173(1):1-9. PubMed ID: 21658718
[TBL] [Abstract][Full Text] [Related]
12. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB
Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y: a novel mechanism for ischemic angiogenesis.
Zukowska Z; Grant DS; Lee EW
Trends Cardiovasc Med; 2003 Feb; 13(2):86-92. PubMed ID: 12586445
[TBL] [Abstract][Full Text] [Related]
14. Expression and precursor processing of neuropeptide Y in human pheochromocytoma and neuroblastoma tumors.
O'Hare MM; Schwartz TW
Cancer Res; 1989 Dec; 49(24 Pt 1):7010-4. PubMed ID: 2582442
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.
Lee EW; Michalkiewicz M; Kitlinska J; Kalezic I; Switalska H; Yoo P; Sangkharat A; Ji H; Li L; Michalkiewicz T; Ljubisavljevic M; Johansson H; Grant DS; Zukowska Z
J Clin Invest; 2003 Jun; 111(12):1853-62. PubMed ID: 12813021
[TBL] [Abstract][Full Text] [Related]
16. Human neuroblastoma cells express alpha and beta platelet-derived growth factor receptors coupling with neurotrophic and chemotactic signaling.
Matsui T; Sano K; Tsukamoto T; Ito M; Takaishi T; Nakata H; Nakamura H; Chihara K
J Clin Invest; 1993 Sep; 92(3):1153-60. PubMed ID: 8376577
[TBL] [Abstract][Full Text] [Related]
17. Role of neuropeptide Y and dipeptidyl peptidase IV in regulation of Ewing's sarcoma growth.
Kitlinska J; Kuo L; Abe K; Pons J; Yu M; Li L; Tilan J; Toretsky J; Zukowska Z
Adv Exp Med Biol; 2006; 575():223-9. PubMed ID: 16700526
[No Abstract] [Full Text] [Related]
18. Neuroprotective effect of neuropeptide Y against β-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin production.
Croce N; Dinallo V; Ricci V; Federici G; Caltagirone C; Bernardini S; Angelucci F
Neurodegener Dis; 2011; 8(5):300-9. PubMed ID: 21346312
[TBL] [Abstract][Full Text] [Related]
19. High expression of neuropeptide Y1 receptors in ewing sarcoma tumors.
Körner M; Waser B; Reubi JC
Clin Cancer Res; 2008 Aug; 14(16):5043-9. PubMed ID: 18698022
[TBL] [Abstract][Full Text] [Related]
20. Aiming at neuroblastoma and hitting other worthy targets.
Schor NF
J Child Neurol; 2013 Jun; 28(6):768-73. PubMed ID: 23576410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
